| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9b46eb221f0d4155a6852bece9f00596
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f9b2ac278f01caa64813fc05aa532ae5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_fe76279626420de6e5fe18e89ef85b98
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e313210954c5c05fe0aa7963549b5819
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1e2b612a52df4378accd2360a43c9c0e |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P33-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-395 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P33-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-002
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-02 |
| filingDate |
1997-09-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0e52ca1c254e17f7ce7a3bc614d13fb0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7dc6fd5d6192170edf9b43500a26edfe
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_550974e5b85392be0fe3a01d80eb010e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6c8eff40752793ca4481ed7026bd947a |
| publicationDate |
1998-04-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-9814212-A1 |
| titleOfInvention |
Method of producing active immunity with vaccine conjugate |
| abstract |
A method of producing active immunity against a bacterial or protozoal disease in a subject comprises administering to the subject a vaccine conjugate comprising a live bacterial or protozoa and a neutralizing factor bound to the live bacterial or protozoa. The neutralizing factor is selected from the group consisting of antibodies and antibody fragments. The live bacterial or protozoa is one capable of producing disease in the subject, and the antibody or antibody fragment is one capable of neutralizing the live bacteria or protozoa. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2842569-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7166290-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8840879-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9107865-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0158486-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6495146-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2014097154-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0158486-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8916518-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7018640-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6627205-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6500438-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7229615-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6984378-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9966953-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9966953-A2 |
| priorityDate |
1996-09-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |